Althea Group Holdings
- Short interest
- 0.00%
- −0.98 pp 30d
- as of 6 Nov 2024
- Reported shorts
- 20K
- Shares on issue
- 405.332M
Althea Group Holdings (AGH) Short Interest
Althea Group Holdings (ASX:AGH) had 0.00% of shares reported as short positions as of 6 Nov 2024, representing 20,039 shares. Althea Group Holdings operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Althea Group Holdings
Althea Group Holdings Limited operates in the medicinal cannabis industry, focusing on the production and distribution of cannabis-based medicines in Australia and international markets. The company leverages its licenses to import, cultivate, and manufacture medicinal cannabis, catering to a growing demand for healthcare solutions in this sector. Althea aims to enhance patient access through diversified product offerings and strategic partnerships.
Company profile →Althea Group Holdings (ASX:AGH) has 0.00% of its shares on issue reported as short positions as of 6 Nov 2024, or about 20,039 shares. Over the past 30 days that figure has fallen 0.98 percentage points, and over 90 days it has fallen 0.98 percentage points. Its highest recorded short interest was 0.99% in July 2024. AGH is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads AGH today
- Zanger BreakoutWatchScore 26rank 770 of 1942
- CAN SLIMWatchScore 20rank 645 of 1541
- Minervini Trend TemplateWatchScore 15rank 1093 of 1716
- Crowded-Short BreakoutWatchScore 9rank 1048 of 1500
- Quality compoundersNot a candidate
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
Latest AGH news
All news- Initial Director's Interest Notice - Z Fleisher-Sharbanee
asx · 5 Oct 2026
- Appointment of Executive Director
asx · 30 Sept 2026
- Appendix 4G
asx · 29 Sept 2026
Company details
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss AGH
Start a research thread or post the first pulse update